Lakefront Biotherapeutics | GLPG - Market Capitalization


Lakefront Biotherapeutics reported EUR1.62B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 44.38B 7.45B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 18.73B 660M Mar/2026
Merck EUR 46.78B 6.52B Mar/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026